Similar Posts
Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies (Pending:AKTS)
Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies Source link
Not so Shining India
Source : Financial Times Source link
Natco Pharma Launched a Generic Version of Celgene’s Pomalyst in US
March 3, 2026March 3, 2026 Natco Pharma Ltd said on Tuesday, 3 March, that it and its partner Breckenridge Pharmaceutical have introduced Pomalidomide capsules, a generic version of Celgene’s Pomalyst, in the United States. The capsules, a thalidomide analogue, are indicated for the treatment of adult patients with multiple…
Part 1: Current State of the Housing Market; Overview for mid-March 2025
by Calculated Risk on 3/10/2025 10:36:00 AM Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2025 A brief excerpt: This 2-part overview for mid-March provides a snapshot of the current housing market. Inventory, inventory, inventory! Inventory usually tells the tale. Currently I’m watching months-of-supply…
Park National Corp OH Trims Stock Position in Ford Motor (NYSE:F)
Park National Corp OH reduced its stake in Ford Motor (NYSE:F – Free Report) by 50.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 110,488 shares of the auto manufacturer’s stock after selling 114,020 shares during the quart Source link
